News|Articles|June 12, 2024

SCAN Health’s Sachin Jain: 'We Must Critically Assess Ourselves to Simplify Healthcare' | AHIP 2024

In an interview prior to the AHIP 2024 conference in Las Vegas, MHE spoke with Sachin H. Jain, M.D.,MBA, CEO, SCAN Group and SCAN Health Plan, who acknowledged that while SCAN isn't perfect, they are ahead in simplifying healthcare by recognizing their role in the problem.

The interview was edited for clarity.

In an interview prior to the AHIP 2024 conference in Las Vegas, MHE spoke with Sachin H. Jain, M.D.,MBA, CEO, SCAN Group and SCAN Health Plan, who acknowledged that while SCAN isn't perfect, they are ahead in simplifying healthcare by recognizing their role in the problem.

Jain shared that SCAN excels in member service with onshore calls by knowledgeable staff and aims to minimize co-pays for essential services.

Their SCAN Classic product has low out-of-pocket costs and no co-pays for primary care, specialists, or hospitalizations, he added.

Despite these efforts, they face challenges, such as a complicated OTC benefits catalog, which they are working to improve.

"It starts with just taking a hard, critical, objective look at ourselves," he said.

Jain also highlighted the industry's tendency to excessively celebrate itself, stressing the need to acknowledge and address shortcomings.


Related to this article

Pooja Roy, M.D., on Precedex-induced fever | CHEST 2026
Pooja Roy, M.D., of Houston Methodist Hospital, discusses how Precedex (dexmedetomidine), an ICU sedative, sometimes triggers noninfectious fever, sparking costly sepsis workups, and the need for a test could help clinicians identify the drug as a cause of fever in ICUs.
Eric K. Singhi, M.D., on lung cancer among younger adults
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.